About Us
    Overview
    Team
        Leadership Team
    Milestones
Radio Therapeutics
    Pipeline
    Programs
    UniRDCTM
Radio Technology
    Manufacturing
    Logistics
Partnering
Media
    Press Releases
        Full-Life Technologies Launches with $10M Seed Round Financing to Advance Its Nuclear Technology & Nuclear Medicines Businesses
        Full-Life Technologies Announces Senior Executive Team Appointments
        Full-Life Technologies Completes $37 Million (USD)Series A Financing to Accelerate Development of its Radiopharmaceutical Pipeline and Radiotechnology Production Platform
        Full-Life Technologies Deepens Radioisotope Technology Expertise with Key Leadership Appointments and the Establishment of a Radioisotope Technology Advisory Board
        Full-Life Technologies to Acquire Focus-X Therapeutics, Bolstering Peptide-Focused Radiopharmaceutical Pipeline
        Full-Life Technologies Announces Appointment of Steffen Heeger, MD, PhD, as Chief Medical Officer and Fa Liu, PhD, as Chief Scientific Officer
        Full-Life Technologies Announces Land Purchase in Belgium to Establish GMP Manufacturing Facility for Radiopharmaceutical Drug Production
        Full-Life Technologies Breaks Ground for GMP Manufacturing Facility in Belgium to Advance Its End-to-end Solution for Radiopharmaceuticals
        Global radiotherapeutics company Full-Life Technologies announces USD $47.3 million Series B financing, Prosperity7 Ventures jointly leads the round
        Full-Life Technologies and Eckert & Ziegler Sign Actinium-225 Supply Agreement for Next Generation Radiopharmaceuticals
        Full-Life Technologies will present preclinical data of its novel PSMA-targeted RDC program 225Ac-FL-020 at the AACR Annual Meeting 2024
    Media Reports
        FIERCE Biotech | Full-Life wants more, acquires New Jersey biotech in efforts to dominate radiopharmaceutical R&D
        ENDPOINTS NEWS | With ops spanning Belgium and China, Full-Life inks $245M buyout to beef up radiopharma pipeline
        ENDPOINTS NEWS | Trailing Novartis and Eli Lilly, radiopharmaceuticals startup Full-Life Technologies nabs $63M to test new PSMA drug
Career
Contact